MedTrace Logo

SOLARIS Endoprosthesis in Iliac Occlusive Disease

NCT03606629 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2022-05-10

No results posted yet for this study

Summary

Fifty patients will be treated with Solaris Endoprosthesis and followed up to 2 years with Walking Impairment Questionnaire and Doppler Ultrasound evaluation in 30 days, 6 months and 12 months.

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

Endoprosthesis implantation

Endoprosthesis implantation by Percutaneous Angioplasty

Sponsors & Collaborators

  • Scitech Produtos Medicos Ltda

    lead INDUSTRY

Principal Investigators

  • Luiz Furuya, MD · Santa Casa de Misericórdia de Santo Amaro

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2021-04-30
Completion
2022-04-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03606629 on ClinicalTrials.gov